As of April 18, 2025, Aelis Farma SA (AELIS.PA) has a market cap of $18.157 million USD. According to our data, Aelis Farma SA is ranked No.8594 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 18, 2025 | $18.16 M |
-41.50%
|
Dec 31, 2024 | $31.04 M |
-84.73%
|
Dec 29, 2023 | $0.20 B |
-3.25%
|
Dec 30, 2022 | $0.21 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Jazz Pharmaceuticals
JAZZ
|
$6.24 B |
0.000 M
|
![]() Ireland
|
![]() Sage Therapeutics
SAGE
|
$0.46 B |
-0.000 M
|
![]() USA
|
![]() Marinus Pharmaceuticals
MRNS
|
$30.37 M |
0.028 M
|
![]() USA
|
![]() Biohaven Pharmaceutical
BHVN
|
$2.08 B |
0.000 M
|
![]() USA
|
![]() ACADIA Pharmaceuticals
ACAD
|
$2.46 B |
0.000 M
|
![]() USA
|
![]() Intra-Cellular Therapies
ITCI
|
$14.05 B |
0.000 M
|
![]() USA
|
![]() Alkermes
ALKS
|
$4.45 B |
-0.000 M
|
![]() Ireland
|
![]() Neurocrine Biosciences
NBIX
|
$10.03 B |
-0.000 M
|
![]() USA
|
![]() Ovid Therapeutics
OVID
|
$20.51 M |
0.000 M
|
![]() USA
|
![]() Voyager Therapeutics
VYGR
|
$0.17 B |
0.000 M
|
![]() USA
|
![]() Minerva Neurosciences
NERV
|
$11.19 M |
0.000 M
|
![]() USA
|
Market Cap | = | AELIS.PA Stock Price | * | AELIS.PA Shares Outstanding |
= | $1.33 | * | 13.62 M | |
= | $18.16 M |